Market Overview

UPDATE: Juno Therapeutics Shares Rise 4.5% Premarket Following Release of 8-K Indicating Payment of $20M Cash, 1.6M Shares to Opus Bio as Conditions to Satisfy License Agreement

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Contracts Pre-Market Outlook Movers

 

Related Articles (JUNO)